Ravin Ratan
@ravinratan.bsky.social
Sarcoma Medical Oncologist at MD Anderson Cancer Center. 90s music afficionado. Minivan driver. Views are mine, though you are also welcome to them.
We’ve been waiting!
February 16, 2025 at 3:08 PM
We’ve been waiting!
At the time, this was the best reference I could find: pubmed.ncbi.nlm.nih.gov/22098102/ Some or most of these patients might have been regular Ewing--the metastatic risk is not 0, and most patients received chemo.
Dilemma remains whether or not we should deescalate treatment in these patients.
Primary cutaneous Ewing sarcoma: a systematic review focused on treatment and outcome - PubMed
This systematic review demonstrated epidemiological and prognostic differences between Ewing sarcoma of the bone and primary cutaneous Ewing sarcoma. Primary cutaneous Ewing sarcoma has a female predo...
pubmed.ncbi.nlm.nih.gov
December 1, 2024 at 4:23 PM
At the time, this was the best reference I could find: pubmed.ncbi.nlm.nih.gov/22098102/ Some or most of these patients might have been regular Ewing--the metastatic risk is not 0, and most patients received chemo.
Dilemma remains whether or not we should deescalate treatment in these patients.
Thanks--it's a really interesting topic. I took care of a patient with what sounds like this entity a few years ago. Small primary skin tumor in a middle aged woman, couldn't call it Ewing until the translocation was identified.
Primary cutaneous Ewing sarcoma: a systematic review focused on treatment and outcome - PubMed
This systematic review demonstrated epidemiological and prognostic differences between Ewing sarcoma of the bone and primary cutaneous Ewing sarcoma. Primary cutaneous Ewing sarcoma has a female predo...
pubmed.ncbi.nlm.nih.gov
December 1, 2024 at 4:23 PM
Thanks--it's a really interesting topic. I took care of a patient with what sounds like this entity a few years ago. Small primary skin tumor in a middle aged woman, couldn't call it Ewing until the translocation was identified.
Nice to read you!
November 24, 2024 at 3:46 AM
Nice to read you!
Really interesting. Recognize the morphological differences, but wonder if we are justified in treating as anything but Ewing until we understand the natural history.
November 24, 2024 at 3:43 AM
Really interesting. Recognize the morphological differences, but wonder if we are justified in treating as anything but Ewing until we understand the natural history.